BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

NovaRx Corporation 

6828 Nancy Ridge Drive, Suite 100

San Diego  California  92121  U.S.A.
Phone: 858-552-8600 Fax: 858-638-0882


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
NovaRx Corporation Announces Results of Lucanix® Phase III Therapeutic Vaccine Trial for Maintenance Therapy in Non-small Cell Lung Cancer to be Presented at ESMO. 9/26/2013 10:08:46 AM    More...
NovaRx Corporation Announces Results of Lucanix® Phase III Therapeutic Vaccine Trial for Post-frontline Maintenance Therapy in Non-small Cell Lung Cancer to be Presented at ESMO 9/25/2013 10:09:18 AM    More...
NovaRx Corporation Completes Enrollment in Lucanix Pivitol Phase III Therapeutic Vaccine Trial for Post Frontline Maintenace Therapy in Non Small Cell Lung Cancer 6/20/2012 10:39:46 AM    More...
NovaRx Corporation Announces FDA Approval of Protocol Amendment to Special Protocol Assessment (SPA) for Phase III Lucanix(R) Study in Non-Small Cell Lung Cancer 11/4/2009 7:57:04 AM    More...
NovaRx Corporation Appoints Industry Veteran as President and COO 12/4/2008 9:47:11 AM    More...
NovaRx Corporation Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients 8/21/2008 7:30:17 AM    More...
NovaRx Corporation Selects Image Solutions, Inc. (ISI)'s eCTDXPress and ISIWriter 5/1/2008 8:42:33 AM    More...
The Immune Response Corporation, Inc. (IMNR) Announces Receipt Of Milestone Payment From NovaRx Corporation 1/5/2007 11:50:51 AM    More...
NovaRx Corporation Release: Lucanix Phase II Clinical Data Demonstrates Significantly Increased Survival In Lung Cancer Patients 6/5/2006 10:22:27 AM    More...
NovaRx Corporation To Present Lucanix Phase II Clinical Data At American Society of Clinical Oncology 5/31/2006 10:19:59 AM    More...
12